Financial Daily from THE HINDU group of publications
Tuesday, Dec 09, 2003

News
Features
Stocks
Port Info
Archives

Group Sites

Corporate - Alliances & Joint Ventures


Dr Reddy's inks pact with Croatian co

Our Bureau

Hyderabad , Dec. 8

DR Reddy's Laboratories Ltd has announced that it has signed an agreement with PLIVA for development and marketing of oncology products in Europe.

PLIVA is a global pharmaceuticals company based in Zagreb, Croatia, and the agreement covers the development and marketing for 11 Oncology products.

Under the agreement, Dr Reddy's would develop the Active Pharmaceutical Ingredients and prepare the drug master file, while PLIVA would be responsible for developing the formulations and preparing the dossier for filing marketing authorisation applications.

By the same contract, PLIVA was granted exclusive marketing rights for 11 central and East European (CEE) countries, and semi-exclusive rights for the rest of CEE countries and Western Europe.

Article E-Mail :: Comment :: Syndication

Stories in this Section
Maruti rolls out upgraded version of Grand Vitara


Ranbaxy's Augmentin gets US clearance
BPCL completes first interest rate swap
Microseal launches products in India
Environment-friendly paper from ITC
Futura Polyesters board meet on Dec 13
Padam Cotton gets shareholders' nod for disposing assets
Excel Ind to sell land at Amboli
Ex gratia for retd IOC staff
HR transformation: How ready are Indian cos?
NTC revamp may result in region-wise mills groupings
Zee arms may be merged with parent
Court okays Taj GVK, Punjab Hotels merger
Dr Reddy's inks pact with Croatian co
Pentair pins hopes on Everpure water filters for more biz
Benz cars top sales target


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

Copyright © 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line